These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38455766)

  • 1. Circulating serum miR-362-3p and miR-6721-5p as potential biomarkers for classification patients with adult-type diffuse glioma.
    Niemira M; Bielska A; Chwialkowska K; Raczkowska J; Skwarska A; Erol A; Zeller A; Sokolowska G; Toczydlowski D; Sidorkiewicz I; Mariak Z; Reszec J; Lyson T; Moniuszko M; Kretowski A
    Front Mol Biosci; 2024; 11():1368372. PubMed ID: 38455766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a miRNA-mRNA regulatory network for post-stroke depression: a machine-learning approach.
    Qiu H; Shen L; Shen Y; Mao Y
    Front Neurol; 2023; 14():1096911. PubMed ID: 37528851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer.
    Niemira M; Erol A; Bielska A; Zeller A; Skwarska A; Chwialkowska K; Kuzmicki M; Szamatowicz J; Reszec J; Knapp P; Moniuszko M; Kretowski A
    Sci Rep; 2023 Nov; 13(1):19287. PubMed ID: 37935712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miRNAs as Diagnostic and Prognostic Biomarkers in High-Grade Gliomas.
    Wu J; Al-Zahrani A; Beylerli O; Sufianov R; Talybov R; Meshcheryakova S; Sufianova G; Gareev I; Sufianov A
    Front Oncol; 2022; 12():898537. PubMed ID: 35646622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-330-3p and miR-485-5p as biomarkers for glioblastoma: An integrated bioinformatics and experimental study.
    Rahmati Y; Alivand M; Mollanoori H
    Comput Biol Chem; 2021 Jun; 92():107458. PubMed ID: 33761401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep sequencing of circulating exosomal microRNA allows non-invasive glioblastoma diagnosis.
    Ebrahimkhani S; Vafaee F; Hallal S; Wei H; Lee MYT; Young PE; Satgunaseelan L; Beadnall H; Barnett MH; Shivalingam B; Suter CM; Buckland ME; Kaufman KL
    NPJ Precis Oncol; 2018; 2():28. PubMed ID: 30564636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on identification of a three-microRNA panel in serum for diagnosing neonatal early onset sepsis.
    Zhao Y; Lu C; Zhu R; Hu X
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2280527. PubMed ID: 37968923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Sequencing-Based Identification of Serum Exosomal Differential miRNAs in High-Grade Glioma and Intracranial Lymphoma.
    Wang S; Xu Z; Zhang C; Yu R; Jiang J; Wang C; Qu C
    Biomed Res Int; 2020; 2020():2102645. PubMed ID: 33083454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1.
    Wang L; Liu Y; Yu Z; Gong J; Deng Z; Ren N; Zhong Z; Cai H; Tang Z; Cheng H; Chen S; He Z
    J Transl Med; 2021 May; 19(1):213. PubMed ID: 34001135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
    Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
    Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating exosomal miRNAs as novel biomarkers for acute aortic dissection: A diagnostic accuracy study.
    Zhang D; Zhao X; Wang B; Liu X; Aizezi A; Ma X
    Medicine (Baltimore); 2023 Jul; 102(30):e34474. PubMed ID: 37505131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic, grading and prognostic role of a restricted miRNAs signature in primary and metastatic brain tumours. Discussion on their therapeutic perspectives.
    Nikolova E; Georgiev C; Laleva L; Milev M; Spiriev T; Stoyanov S; Taseva-Mineva T; Mitev V; Todorova A
    Mol Genet Genomics; 2022 Mar; 297(2):357-371. PubMed ID: 35064290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
    Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
    Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
    Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
    Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test.
    Li R; Xia Y; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Li M; Lin Y; Dong J; Ji L; Lai Y
    Transl Cancer Res; 2022 May; 11(5):1005-1016. PubMed ID: 35706801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
    Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
    Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer.
    Fan X; Zou X; Liu C; Cheng W; Zhang S; Geng X; Zhu W
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34076696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy.
    Krell A; Wolter M; Stojcheva N; Hertler C; Liesenberg F; Zapatka M; Weller M; Malzkorn B; Reifenberger G
    Neuropathol Appl Neurobiol; 2019 Aug; 45(5):441-458. PubMed ID: 30548945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Serum miRNAs as Effective Diagnostic Biomarkers for Distinguishing Primary Central Nervous System Lymphoma from Glioma.
    Si PP; Zhou XH; Qu ZZ
    J Immunol Res; 2022; 2022():5052609. PubMed ID: 35497882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.